Mark Harvey WILCOX,Simon BAINES,Dario LEHOUX,Thomas R. PARR
申请号：
US14101645
公开号：
US20140100157A1
申请日:
2013.12.10
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and prevention of C. difficile infection and disease in animals, including humans, are described.
